Toshifumi Ashida

As seen in: Gastrointestinal Endoscopy

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Toshifumi

Contact Toshifumi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

Mo1584 COMPARATIVE EFFECTIVENESS AND SAFETY OF THREE JAK INHIBITORS—FILGOTINIB, TOFACITINIB, AND UPADACITINIB—IN PATIENTS WITH ULCERATIVE COLITIS: A MULTICENTER REAL-WORLD STUDY IN JAPAN

May 01, 2026 |

By Aki Sakatani, Katsuyoshi Ando, Nobuhiro Ueno, Takahiro Ito, Atsuo Maemoto, Asako Nomura, Takehiko Katsurada, Yoshihiro Yokoyama, Daisuke Hirayama, Shigeru Furukawa, Masanao Nasuno, Hiroki Tanaka, Fumika Orii, Toshifumi Ashida, Satoshi Motoya, Mikihiro Fuj

| Gastrointestinal Endoscopy

Also available on ScienceDirect

Open in Who Shared

See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with Toshifumi

Contact Toshifumi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

For PR Teams

Overview

Use Cases

Capabilities

Industries

Introducing Curation Engine

Resources

Library

Commmunity

Customers

Company

Toshifumi Ashida

Get in touch with Toshifumi

Actions

Is this you?

Articles

Mo1584 COMPARATIVE EFFECTIVENESS AND SAFETY OF THREE JAK INHIBITORS—FILGOTINIB, TOFACITINIB, AND UPADACITINIB—IN PATIENTS WITH ULCERATIVE COLITIS: A MULTICENTER REAL-WORLD STUDY IN JAPAN

Actions

Is this you?

Get in touch with Toshifumi